Download Files:
NPS-1034
SKU
HY-100509-10 mg
Category Reference compound
Tags Apoptosis;c-Met/HGFR;TAM Receptor, Apoptosis;Protein Tyrosine Kinase/RTK, Cancer
$80 – $490
Products Details
Product Description
– NPS-1034 is a dual inhibitor of AXL and MET with IC50s of 10.3 and 48 nM, respectively.
Web ID
– HY-100509
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C31H23F2N5O3
References
– [1]Rho JK, et al. MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation. Cancer Res. 2014 Jan 1;74(1):253-62.|[2]Shin JS, et al. NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants. Invest New Drugs. 2014 Jun;32(3):389-99.
CAS Number
– 1221713-92-3
Molecular Weight
– 551.54
Compound Purity
– 98.0
SMILES
– O=C(C1=C(C)N(C)N(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C5C(NC=C5C6=CC=CC=C6)=NC=C4)C(F)=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 34 mg/mL (ultrasonic)
Target
– Apoptosis;c-Met/HGFR;TAM Receptor
Pathway
– Apoptosis;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.